160 related articles for article (PubMed ID: 36477537)
1. Structural variants drive context-dependent oncogene activation in cancer.
Xu Z; Lee DS; Chandran S; Le VT; Bump R; Yasis J; Dallarda S; Marcotte S; Clock B; Haghani N; Cho CY; Akdemir KC; Tyndale S; Futreal PA; McVicker G; Wahl GM; Dixon JR
Nature; 2022 Dec; 612(7940):564-572. PubMed ID: 36477537
[TBL] [Abstract][Full Text] [Related]
2. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
[TBL] [Abstract][Full Text] [Related]
3. The effects of common structural variants on 3D chromatin structure.
Shanta O; Noor A; ; Sebat J
BMC Genomics; 2020 Jan; 21(1):95. PubMed ID: 32000688
[TBL] [Abstract][Full Text] [Related]
4. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer.
Du Y; Gu Z; Li Z; Yuan Z; Zhao Y; Zheng X; Bo X; Chen H; Wang C
Adv Sci (Weinh); 2022 Jun; 9(18):e2200818. PubMed ID: 35570408
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide detection of enhancer-hijacking events from chromatin interaction data in rearranged genomes.
Wang X; Xu J; Zhang B; Hou Y; Song F; Lyu H; Yue F
Nat Methods; 2021 Jun; 18(6):661-668. PubMed ID: 34092790
[TBL] [Abstract][Full Text] [Related]
7. Somatic structural variant formation is guided by and influences genome architecture.
Sidiropoulos N; Mardin BR; Rodríguez-González FG; Bochkov ID; Garg S; Stütz AM; Korbel JO; Aiden EL; Weischenfeldt J
Genome Res; 2022 Apr; 32(4):643-655. PubMed ID: 35177558
[TBL] [Abstract][Full Text] [Related]
8. Polymer physics predicts the effects of structural variants on chromatin architecture.
Bianco S; Lupiáñez DG; Chiariello AM; Annunziatella C; Kraft K; Schöpflin R; Wittler L; Andrey G; Vingron M; Pombo A; Mundlos S; Nicodemi M
Nat Genet; 2018 May; 50(5):662-667. PubMed ID: 29662163
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
10. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.
Akdemir KC; Le VT; Chandran S; Li Y; Verhaak RG; Beroukhim R; Campbell PJ; Chin L; Dixon JR; Futreal PA; ;
Nat Genet; 2020 Mar; 52(3):294-305. PubMed ID: 32024999
[TBL] [Abstract][Full Text] [Related]
11. 3D-GNOME 2.0: a three-dimensional genome modeling engine for predicting structural variation-driven alterations of chromatin spatial structure in the human genome.
Wlasnowolski M; Sadowski M; Czarnota T; Jodkowska K; Szalaj P; Tang Z; Ruan Y; Plewczynski D
Nucleic Acids Res; 2020 Jul; 48(W1):W170-W176. PubMed ID: 32442297
[TBL] [Abstract][Full Text] [Related]
12. When 3D genome changes cause disease: the impact of structural variations in congenital disease and cancer.
Weischenfeldt J; Ibrahim DM
Curr Opin Genet Dev; 2023 Jun; 80():102048. PubMed ID: 37156210
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
[TBL] [Abstract][Full Text] [Related]
14. Integrative detection and analysis of structural variation in cancer genomes.
Dixon JR; Xu J; Dileep V; Zhan Y; Song F; Le VT; Yardımcı GG; Chakraborty A; Bann DV; Wang Y; Clark R; Zhang L; Yang H; Liu T; Iyyanki S; An L; Pool C; Sasaki T; Rivera-Mulia JC; Ozadam H; Lajoie BR; Kaul R; Buckley M; Lee K; Diegel M; Pezic D; Ernst C; Hadjur S; Odom DT; Stamatoyannopoulos JA; Broach JR; Hardison RC; Ay F; Noble WS; Dekker J; Gilbert DM; Yue F
Nat Genet; 2018 Oct; 50(10):1388-1398. PubMed ID: 30202056
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers.
Alaei-Mahabadi B; Bhadury J; Karlsson JW; Nilsson JA; Larsson E
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13768-13773. PubMed ID: 27856756
[TBL] [Abstract][Full Text] [Related]
16. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Zhang Y; Chen F; Fonseca NA; He Y; Fujita M; Nakagawa H; Zhang Z; Brazma A; ; ; Creighton CJ;
Nat Commun; 2020 Feb; 11(1):736. PubMed ID: 32024823
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
18. Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer.
Kim K; Kim M; Lee AJ; Song SH; Kang JK; Eom J; Kang GH; Bae JM; Min S; Kim Y; Lim Y; Kim HS; Kim YJ; Kim TY; Jung I
Cell Rep; 2023 Jul; 42(7):112778. PubMed ID: 37453058
[TBL] [Abstract][Full Text] [Related]
19. Prioritization of genes driving congenital phenotypes of patients with de novo genomic structural variants.
Middelkamp S; Vlaar JM; Giltay J; Korzelius J; Besselink N; Boymans S; Janssen R; de la Fonteijne L; van Binsbergen E; van Roosmalen MJ; Hochstenbach R; Giachino D; Talkowski ME; Kloosterman WP; Cuppen E
Genome Med; 2019 Dec; 11(1):79. PubMed ID: 31801603
[TBL] [Abstract][Full Text] [Related]
20. A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.
Zhang Y; Yang L; Kucherlapati M; Chen F; Hadjipanayis A; Pantazi A; Bristow CA; Lee EA; Mahadeshwar HS; Tang J; Zhang J; Seth S; Lee S; Ren X; Song X; Sun H; Seidman J; Luquette LJ; Xi R; Chin L; Protopopov A; Li W; Park PJ; Kucherlapati R; Creighton CJ
Cell Rep; 2018 Jul; 24(2):515-527. PubMed ID: 29996110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
